文献速递腹部介入CTDSA

介入放射学处理胰十二指肠切除术后并发症的单中心经验

Interventional radiology in the management of complications after pancreatic surgery: a single-center experience.
PubMed 文献 · Abdom Radiol (NY) · 2026-07-02

回顾性分析200例胰十二指肠切除术患者,评估介入放射学作为术后主要并发症一线挽救治疗的作用。126例出现并发症,75例需早期再干预,其中63例由介入完成。在临床相关胰瘘亚组中,介入优先组90天死亡率低于手术优先组(15.2% vs 53.3%,p=0.012),但未调整分析的结果在调整临床严重程度后减弱。

要点

  • 术后胰瘘和出血的介入一线处理可减少再次手术探查,需熟悉引流与栓塞路径。
  • 临床相关胰瘘中优先介入与较低90天死亡率相关,但调整严重程度后关联减弱。
  • 胆道并发症97.0%由介入处理,提示介入在胆道并发症管理中的核心地位。

核心结论

  • 大部分胰十二指肠切除术后主要并发症可通过微创介入技术控制,从而减少再次手术探查。
  • 在未调整分析中介入优先策略与较低90天死亡率相关,但调整临床严重程度后该关联减弱。

研究设计与样本

  • 回顾性单中心队列研究,纳入200例2014至2025年间连续接受胰十二指肠切除术的患者。
  • 并发症按ISGPS/ISGLS定义记录,术后胰瘘包括生化漏,患者按初始处理策略分为介入优先组和手术优先组。
  • 结局指标包括再干预需求、技术成功率、住院时间和90天死亡率,采用Fisher精确检验比较亚组死亡率。
  • 证据等级为Level 3,治疗性研究。

诊断标准与关键数值

  • 术后胰瘘发生率39.5%(79/200),临床相关胰瘘发生率24.5%(49/200)。
  • 临床相关胰瘘亚组中,67.3%(33/49)接受影像引导引流,30.6%(15/49)需要再次探查。
  • 介入优先组90天死亡率为15.2%(5/33),手术优先组为53.3%(8/15),p=0.012,为未调整分析。
  • 胰腺切除术后出血发生率13.0%(26/200),栓塞实施率61.5%(16/26),其中仅6.3%(1/16)升级为手术。

临床应用与阅片要点

  • 对临床相关胰瘘应优先考虑影像引导经皮引流,可减少再次手术探查并可能改善短期预后。
  • 对胰腺切除术后出血应积极评估血管造影和栓塞,栓塞后升级手术的比例很低。
  • 胆道并发症可首先交由介入处理,本研究中97.0%(32/33)以介入为主要处理方式。
  • 解读介入治疗后病情变化时,应采用阶梯升级框架,交叉到手术不应简单视为介入失败。

局限性

  • 回顾性单中心设计存在选择偏倚,介入优先与手术优先组的临床严重程度不均衡,调整后死亡率关联减弱。
  • 未调整的死亡率比较受混杂影响,需要前瞻性多中心研究进一步细化选择标准和阶梯治疗方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the impact of interventional radiology (IR) as first-line rescue therapy for major complications after pancreaticoduodenectomy and to quantify its effect on surgical re-exploration and 90-day mortality.

MATERIALS AND METHODS: In this retrospective single-center cohort, 200 consecutive patients undergoing pancreaticoduodenectomy (2014-2025) were reviewed. Complications were recorded using ISGPS/ISGLS definitions; postoperative pancreatic fistula (POPF) included biochemical leak. Patients were grouped by initial management strategy (IR-first vs. primary surgery); crossover to the alternative treatment was recorded and interpreted within a step-up management framework rather than uniformly as treatment failure. Outcomes included need for re-intervention, technical success, length of stay, and 90-day mortality. Fisher's exact test compared mortality between strategies within clinically relevant POPF (CR-POPF) and postpancreatectomy hemorrhage (PPH) subgroups.

RESULTS: Overall, 126/200 patients (63%) developed postoperative complications and 75/126 (59.5%) required early re-intervention. IR accounted for 63/75 reinterventions (84.0%). POPF occurred in 79/200 (39.5%); CR-POPF in 49/200 (24.5%). Among CR-POPF, 33/49 (67.3%) underwent image-guided drainage and 15/49 (30.6%) required re-exploration; 90-day mortality was lower with IR-first than surgery-first management in unadjusted analysis (5/33, 15.2% vs. 8/15, 53.3%; p = 0.012). PPH occurred in 26/200 (13.0%); embolization was performed in 16/26 (61.5%) with low step-up to surgery (1/16, 6.3%). Mortality did not differ significantly between embolization-only and re-exploration-only pathways (3/16, 18.8% vs. 4/8, 50.0%; p = 0.182). Biliary complications were managed primarily with IR in 32/33 patients (97.0%).

CONCLUSION: A substantial proportion of major post-pancreaticoduodenectomy complications can be controlled with minimally invasive IR techniques, limiting surgical re-exploration. IR-first strategy was associated with lower 90-day mortality in unadjusted analysis; however, this association was attenuated after adjustment for clinical severity. Prospective multicenter studies are needed to further refine selection criteria and step-up treatment algorithms.

LEVEL OF EVIDENCE: Level 3, therapeutic study.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Pacella, Olivieri, Altomare, et al. Interventional radiology in the management of complications after pancreatic surgery: a single-center experience. Abdom Radiol (NY). 2026. PMID: 42390777. doi:10.1007/s00261-026-05591-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。